Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Jun 30, 2017

Filed with the SEC on Aug 7, 2017 and accepted by EDGAR at Aug 7, 2017, 16:10 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-04-01 to 2017-06-30$14.0kus-gaap:Revenues
Revenue6 months2017-01-01 to 2017-06-30$25.0kus-gaap:Revenues
Research and development3 months2017-04-01 to 2017-06-30$9.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2017-01-01 to 2017-06-30$19.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-04-01 to 2017-06-30$14.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2017-01-01 to 2017-06-30$30.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-04-01 to 2017-06-30−$23.8mus-gaap:OperatingIncomeLoss
Operating income6 months2017-01-01 to 2017-06-30−$49.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-04-01 to 2017-06-30$154.0kus-gaap:InterestExpense
Interest expense6 months2017-01-01 to 2017-06-30$191.0kus-gaap:InterestExpense
Income tax3 months2017-04-01 to 2017-06-30−$124.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2017-01-01 to 2017-06-30−$222.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-04-01 to 2017-06-30−$23.5mus-gaap:NetIncomeLoss
Net income6 months2017-01-01 to 2017-06-30−$48.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-04-01 to 2017-06-30−$0.29us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2017-01-01 to 2017-06-30−$0.60us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure6 months2017-01-01 to 2017-06-30$12.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2017-01-01 to 2017-06-30$12.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-06-30$39.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-06-30$181.6mus-gaap:AssetsCurrent
Total assetsAt period end2017-06-30$301.6mus-gaap:Assets
Current liabilitiesAt period end2017-06-30$36.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-06-30$48.7mus-gaap:Liabilities
Shareholders' equityAt period end2017-06-30$252.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-17-015981. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.